Log In
BCIQ
Print this Print this
 

Androgen receptor

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Androgen receptor

BCIQ
Print ChartPrint this
0 0 0 1 0 0 0 0 1 0 2 0 1 0 0 0 0 0 0 0 1 0 0 2 1 0 2 1 1 1 1 7 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 8 2 2 3 3 0 0 4
Phases of DevelopmentPreclinicalINDPhase IPhase IIPhase IIIRegistrationApprovedMarketed
Cancer

8

2

2

3

3

0

0

4

Cardiovascular

0

0

1

0

0

0

0

0

Dermatology

0

0

0

1

0

0

0

0

Endocrine / Metabolic

1

0

2

1

1

1

1

7

Genitourinary

0

0

0

0

1

0

0

2

Musculoskeletal

1

0

2

0

1

0

0

0

Neurology

0

0

0

1

0

0

0

0




 Products Targeting Androgen receptor
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

21

$4,757.5M

$2,149.0M

$2,645.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today